Medtronic (MDT) Net Margin (2014 - 2026)

Medtronic (MDT) posted Net Margin of 12.84% for Q2 2026, up 0.66% sequentially from 12.75% in Q1 2026, and up 94.0% YoY from 6.62% in Q2 2025.

Medtronic (MDT) Net Margin (2014 - 2026) Analysis & Trends

Medtronic has reported Net Margin for 13 years, with the latest figure at 12.84% in Q2 2026.

Quarterly Net Margin rose 94.0% year-over-year to 12.84% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 13.3% (down 68.0% YoY) and the FY2026 annual result came in at 13.3%, down 69.0% from the prior year.
Net Margin climbed to 12.84% in Q2 2026 per MDT's latest filing, from 12.75% in the prior quarter.
Over five years, Net Margin peaked at 19.1% in Q1 2022 and troughed at 5.75% in Q4 2022.
A 5-year average of 13.39% and a median of 13.04% in 2024 frame the typical range for Net Margin.
The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 1104 bps in 2022, then soared 566 bps in 2023.
Over 5 years, Net Margin stood at 5.75% in 2022, then soared by 99 bps to 11.41% in 2023, then soared by 33 bps to 15.21% in 2024, then grew by 1 bps to 15.42% in 2025, then decreased by 17 bps to 12.84% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 12.84%, 12.75%, and 15.42% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	7.37%
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	19.37%
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	12.84%
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	16.67%
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	13.87%
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	19.04%
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	10.84%
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	6.47%
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	13.47%
10	Zimmer Biomet Holdings	19.32 Bn	18.91 Bn	1.54 Bn	9.17%

Download Data